Trademarkia Logo

Australia

AU$
Trademark Search
CONVERGENCE BIO

View On IPO.GOV.AU

CONVERGENCE BIO
Registered: Registered/protected

Last updated on 9 Jan 2025

Owner Info

Convergence Bio, Inc. A Delaware Corporation

800 Boylston St, Ste 2222

Boston, MASSACHUSETTS, 02199 UNITED STATES OF AMERICA,

Serial Number

2490244 filed on 14 Oct 2024

Correspondent

By George Legal

Level 1, Studio 2,

459 Sydney Road,

Brunswick, VIC, 3056 AUSTRALIA

CONVERGENCE BIO

Classification Information

Class [005]
pharmaceutical preparations, vaccines and medical therapeutics for the prevention and treatment of autoimmune, cardiovascular, central nervous system, Read More

Class [042]
research and development of pharmaceutical preparations, vaccines and therapeutic drugs for the prevention and treatment of autoimmune, cardiovascular Read More

Mark Details

Serial Number

2490244

Registered On

14 Oct 2024

Renewal On

14 Oct 2034

Mark Type

WORD

Priority Claim (Convention Details)

Date

30 May 2024

Mark Type

US

Legal History

Show more

Status DateAction Taken
9th Jan 2025IP Right Registered correspondence sent
9th Jan 2025IP Right Registration Published
9th Jan 2025Status change to Registered/Protected
31st Oct 2024Application Accepted correspondence sent
31st Oct 2024IP Right has been Examined
31st Oct 2024IP Right Acceptance Published
22nd Oct 2024Early Acceptance Notice correspondence sent
22nd Oct 2024Status change to Accepted
22nd Oct 2024IP right goods and service classes updated
22nd Oct 2024IP Right Goods and Services Items updated